Relationship between arterial blood gas values, pulmonary function tests and treadmill exercise testing parameters in patients with COPD

Respirology

Volumn 9, Issue 3, 2004, Pages 320-325

  Yazici, Mehmet ^a   Arbak, Peri ^a   Balbay, Oner ^a   Maden, Emin ^b   Erbas, Mete ^a   Erbilen, Enver ^a   Albayrak, Sinan ^a   Akdemir, Ramazan ^a   Uyan, Cihangir ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b Medica Imaging Centre   (Turkey)

Author keywords

COPD; Treadmill exercise testing

Indexed keywords

ADULT; AGED; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; TREADMILL; TREADMILL EXERCISE;

AGED; CARBON DIOXIDE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 6044226670     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00619.x     Document Type: Article

References (45)

1. Epstein SK, Celli BR. Cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease. Cleve. Clin. J. Med. 1993; 60: 119-28.
2. Owens GR, Rogers RM, Pennock BE, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N. Engl. J. Med. 1984; 310: 1218-21.
3. Wasserman K, Whipp BJ. Exercise physiology in health and disease. Am. Rev. Respir. Dis. 1975; 112: 219-49.
4. Brown HV, Wasserman K. Exercise performance in chronic obstructive pulmonary diseases. Med. Clin. North Am. 1981; 65: 525-47.
5. Loke J, Mahler DA, Man SFB, Wiedemann HP, Matthay RA. Exercise impairment in chronic obstructive pulmonary disease. Clin. Chest Med. 1984; 5: 121-43.
6. Gallagher CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin. Chest Med. 1994; 15: 305-26.
7. Marciniuk DD, Gallagher CG. Clinical exercise testing in chronic airflow limitation. Med. Clin. North Am. 1996; 80: 565-87.
8. American Thoracic Society. Evaluation of impairment/ disability secondary to respiratory disorders. Am. Rev. Respir. Dis 1986; 133: 1205-9.
9. Ries AL. The role of exercise testing in pulmonary diagnosis. Clin. Chest Med. 1987; 8: 81-9.
10. Olsen GN. The evolving role of exercise testing prior to lung resection. Chest 1989; 95: 218-25.
11. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of Exercise Testing and Interpretation. Lea-Febiger, Philadelphia, 1999; 72-86.
12. Wasserman K. Dyspnea on exertion: is it the heart or the lungs? JAMA 1982; 248: 2039-43.
13. Jones NL, Jones G, Edwards RHT. Exercise tolerance in chronic airway obstruction. Am. Rev. Respir. Dis. 1971; 103: 477-91.
14. Cotes JE, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am. Rev. Respir. Dis. 1988; 137: 1089-93.
15. Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest 1991; 100: 307-11.
16. Ortega F, Montemayor T, Sanchez A, Cabello F, Castillo J. Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med. 1994; 150: 747-51.
17. Matthews JI, Bush BA, Ewald FW. Exercise responses during incremental and high intensity and low intensity steady state exercise in patients with obstructive lung disease and normal control subjects. Chest 1989; 96: 11-7.
18. Becklake MR, Rodarte JR, Kalica AR. NHLBI workshop summary. Scientific issues in the assessment of respiratory impairment. Am. Rev. Respir. Dis. 1988; 137: 1505-10.
19. Killian KJ, Summers E, Jones NL, Campbell EJM. Exercise capacity and the ATS criteria of severe impairment/disability (Abstract). Am. Rev. Respir. Dis. 1990; 141: 830.
20. Pineda H, Haas F, Axen K, Haas A. Accuracy of pulmonary function tests in predicting exercise tolerance in chronic obstructive pulmonary disease. Chest 1984; 86: 564-7.
21. Dillard TA, Piantadosi S, Rajagopal KR. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 1989; 96: 267-71.
22. Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease: the COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52 (Suppl. 5): S1-S28.
23. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am. Rev. Respir. Dis. 1984; 129: S49-S55.
24. Morris JF, Koski A, Johnson LC. Spirometric standarts for healthy nonsmoking adults. Am. Rev. Respir. Dis. 1971; 103: 57-67.
25. Jones NL, Campbell EJM. Clinical Exercise Testing, 2nd edn. W.B. Saunders Company, Philadelphia, 1982; 94-249.
26. Fletcher GF, Balady G, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards: A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation 1995; 91: 580-615.
27. Henry WL, DeMaria A, Gramiak R et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in two-dimensional imaging. Circulation 1980; 62: 212-7.
28. Kaul S, Tei C, Hopkins JM, Shah PM. Assessment of right ventricular function using two-dimensional echocardiography. Am. Heart J. 1984; 107: 526-31.
29. Hammarstrom E, Wranne B, Pinto FJ, Puryear J, Popp RL. Tricuspid annular motion. J. Am. Soc. Echocardiogr. 1991; 4: 131-9.
30. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung Volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. 1993; 16 (Suppl. 16): 5-40.
31. Knox AJ, Morrison JF, Muers MF. Reproducibility of walking test results in chronic obstructive airways disease. Thorax 1988; 43: 388-92.
32. Czernicka-Cierpisz E. Exercise tolerance in patients with chronic obstructive pulmonary disease in various stages of advanced disease. Pneumonol. Alergol. Pol. 1996; 64: 604-14 (in Polish).
33. Bye PT, Esau SA, Levy RD et al. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation. Am. Rev. Respir. Dis. 1985; 132: 236-40.
34. Rasche K, Bauer TT, Neumeister W et al. Stress test blood gas analysis in chronic obstructive lung diseases. Pnuemologie 1997; 51: 640-6 (in German).
35. Wagner PD. Effects of COPD on gas exchange. In: Cherniac NS (ed). Chronic Obstructive Pulmonary Disease. W.B. Saunders Company, Philadelphia, 1991; 73-9.
36. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax 1992; 47: 34-40.
37. Levine PA, Klein MD. Mechanisms of arrhythmias in chronic obstructive lung disease. Geriatrics 1976; 31:47-56.
38. Yncalzi RA, Pistelli R, Fuso L, Cocchi A, Bonetti MG, Giordano A. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic obstructive pulmonary disease. Chest 1990; 97: 1092-7.
39. Tirlapur VG, Mir MA. Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N. Engl. J. Med. 1982; 306: 125-30.
40. Shih HT, Webb CR, Conway WA, Peterson E, Tilley B, Goldstein S. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44-8.
41. Biggs FD, Lefrak SS, Kleiger RE, Senior RM, Oliver GC. Disturbances of rhythm in chronic lung disease. Heart Lung 1977; 6: 256-61.
42. Green LH, Smith TW. The use of digitalis in patients with pulmonary disease. Ann. Intern. Med. 1977; 87: 459-65.
43. Bittar G, Friedman HS. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest 1991; 99: 1415-20.
44. Pierson DJ, Hudson LD, Stark K, Hedgecock M. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease. Chest 1980; 77: 176-82.
45. Simmons DN, Berry MJ, Hayes SI, Walschlager SA. The relationship between %HR peak and %VO2 peak in patients with chronic obstructive pulmonary disease. Med. Sci. Sports Exerc. 2000; 32: 881-6.